ICD-10 Code M15.4: Erosive osteoarthritis diagnosis guide

Key Takeaways

ICD-10 Code M15.4 is a fully billable diagnosis code for Erosive (osteo)arthritis, valid through the 2026 ICD-10-CM code year.

M15.4 sits within the M15 Polyosteoarthritis category, a subset of the M15-M19 Osteoarthritis block in Chapter 13 (M00-M99).

The parent code M15 is non-billable; coders must always use a specific subcode such as M15.4 rather than M15 alone.

Pabau’s claims management software helps musculoskeletal and rheumatology practices document and submit M15.4 claims with fewer denials.

ICD-10 Code M15.4: definition and clinical description

ICD-10 Code M15.4 is the billable diagnosis code for Erosive (osteo)arthritis under the CDC/NCHS ICD-10-CM classification system. It is valid for the 2026 ICD-10-CM code year and is fully accepted for insurance claim submission. Practices treating patients with this condition need accurate documentation and consistent code selection to avoid payer denials, particularly when the diagnosis falls near adjacent osteoarthritis codes in the M15-M19 range.

Erosive osteoarthritis is a clinically distinct and more aggressive subtype of osteoarthritis. Unlike typical degenerative joint disease, it involves active synovial inflammation alongside the characteristic bone erosion at interphalangeal joints. Because it presents with features that overlap with inflammatory arthritides, accurate coding with M15.4 is important for both clinical documentation and reimbursement integrity.

The synonym listed in official coding sources is erosive osteoarthrosis. Both terms refer to the same clinical entity and map to the same code. Using an digital intake form that captures joint distribution and inflammatory symptoms helps clinicians document this distinction before the encounter note is finalized.

Code description and official classification

M15.4 sits within a specific hierarchical structure in ICD-10-CM. Understanding where it lives in that hierarchy prevents the most common coding errors with polyosteoarthritis cases.

The key billing point: M15 (parent code) is explicitly non-billable. Payers require the specificity of a subcode. Submitting M15 alone will result in an automatic technical denial. This is also true of the broader M15-M19 block designation and Chapter 13 header codes. Among related ICD-10 diagnostic code references, the pattern of non-billable parent codes requiring specific subcodes is consistent across multiple chapters. Always verify you are billing the most specific code available.

The M15 family: related subcodes for ICD-10 Code M15.4

M15.4 is one of seven subcodes within the M15 category. Choosing the wrong subcode, particularly M15.0 or M15.9, is one of the most common payer queries in rheumatology and physical medicine billing. Pabau’s claims management software flags code specificity gaps before submission, reducing this risk.

• M15.0 Primary generalized (osteo)arthritis: Degenerative joint disease affecting multiple joints without the erosive or inflammatory component. No bone erosion pattern required.
• M15.1 Heberden’s nodes (with arthropathy): Bony enlargements at the distal interphalangeal joints. Distinct from erosive presentation.
• M15.2 Bouchard’s nodes (with arthropathy): Bony enlargements at the proximal interphalangeal joints. Same distinction applies.
• M15.3 Secondary multiple arthritis: Multiple joint arthritis caused by another underlying condition. Etiology drives code selection.
• M15.4 Erosive (osteo)arthritis: Active synovial inflammation with bone erosion at interphalangeal joints. This is the billable code covered in this article.
• M15.8 Other polyosteoarthritis: Residual category for polyosteoarthritis not elsewhere classified.
• M15.9 Polyosteoarthritis, unspecified: Use only when documentation does not support a more specific subcode. Avoid where clinical detail allows specificity.

The AAPC Codify ICD-10-CM lookup provides chapter-specific coding guidelines for the M15 category, including notes on when to assign primary osteoarthritis versus localized codes from the M19 range.

Coding guidelines for ICD-10 Code M15.4 and polyosteoarthritis

The CMS ICD-10-CM Official Guidelines for Coding and Reporting govern how M15.4 is assigned and sequenced. The CMS ICD-10 codes page publishes the current guidelines file each fiscal year. The following rules are the most operationally important for rheumatology and musculoskeletal practices.

Principal versus secondary diagnosis sequencing

When erosive osteoarthritis is the primary reason for the encounter, M15.4 sequences as the principal diagnosis. If the patient presents for a complication of erosive OA (for example, a joint effusion or inflammatory flare requiring aspiration), the complication code may sequence first depending on payer rules and encounter context. Follow the reason for the encounter principle from Section II of the Official Guidelines.

Common secondary diagnoses submitted alongside M15.4 include pain codes (M79.3x for periarticular pain), functional limitation codes, and osteoporosis codes where the patient profile supports dual documentation. Practices using dedicated physical therapy EMR systems can template these secondary diagnosis combinations to reduce per-encounter documentation time.

M15.4 versus M15.0: the most common selection error

M15.0 (Primary generalized osteoarthritis) and M15.4 (Erosive osteoarthritis) are frequently confused. The clinical distinction matters for billing: erosive OA involves active synovial inflammation and characteristic bone erosion at interphalangeal joints, which M15.0 does not require. Radiographic evidence of subchondral erosions is the key differentiator. Submitting M15.0 for a documented erosive presentation understates the complexity of the case and may trigger a post-payment audit if the medical record clearly supports M15.4.

M15.4 versus M19 (localized osteoarthritis)

M19 codes cover primary or secondary osteoarthritis of individual joints other than the hip and knee. Use M19.xx when the presentation is localized to one or two joints. M15.4 applies when erosive changes involve multiple joints in a polyarticular pattern. The interphalangeal joints of the hands are the most common site for erosive OA. When only a single finger joint is documented, M19.04x (Primary osteoarthritis, hand) may be more appropriate than M15.4. Reviewing the coding specificity principles applied across ICD-10 categories reinforces why anatomical distribution documentation drives code selection here.

Streamline musculoskeletal billing with Pabau

Pabau helps rheumatology and musculoskeletal practices document complex diagnoses like M15.4 accurately, reduce claim denials, and keep clinical records audit-ready. See how it works for your practice.

Book a demo

Documentation requirements for ICD-10 Code M15.4 claims

Payers scrutinize erosive osteoarthritis claims because the diagnosis lies at the intersection of degenerative and inflammatory arthritis. Inadequate documentation is the most common reason M15.4 claims face additional development (ADR) requests or post-payment audits. The following documentation elements must be present in the medical record to support this code.

Required clinical elements

• Joint distribution: Name the specific joints affected. “Bilateral proximal and distal interphalangeal joints” is sufficient. “Multiple joints” is not.
• Erosive pattern confirmation: Document either radiographic evidence (subchondral erosions, gull-wing deformity on X-ray) or clinical findings consistent with erosive OA. Reference the imaging report by date and facility.
• Synovial inflammation notation: Note the presence of soft-tissue swelling, warmth, or synovitis at the affected joints. This distinguishes erosive OA from non-erosive polyosteoarthritis.
• Etiology exclusion: Brief statement ruling out rheumatoid arthritis or psoriatic arthritis, particularly if RF or anti-CCP was tested. Payers may question M15.4 if inflammatory arthritis workup is documented without a clear exclusion statement.
• Functional impact: Note limitations in grip strength, range of motion, or activities of daily living where applicable. This supports medical necessity for associated therapy or medication management codes billed on the same claim.

Using structured client record management with pre-built musculoskeletal templates helps practitioners capture these elements consistently across every encounter, not just when an audit is anticipated. Practices applying structured ICD-10 documentation practices across their codebase see fewer post-payment queries overall.

ICD-9 to ICD-10-CM crosswalk for erosive osteoarthritis

For practices migrating historical records or researching legacy claims, the approximate ICD-9-CM predecessor codes for erosive osteoarthritis fall within the 715.xx range. These crosswalks are approximate; ICD-9 lacked the specificity of ICD-10-CM’s M15 subcode structure.

These mappings are approximate and should not be used for current-year claim submission. Use the AAPC Codify ICD-10-CM lookup or the CDC/NCHS ICD-10-CM web tool for authoritative crosswalk verification. Practices that support rheumatology billing alongside physiotherapy clinic compliance requirements should review crosswalk documentation during annual coding updates.

Denial prevention and payer-specific considerations

Erosive osteoarthritis claims attract more payer scrutiny than standard M15.0 or M19.90 submissions because the diagnosis combines degenerative and inflammatory features. Most commercial payers and Medicare do not require prior authorization for the diagnosis code itself, but they may request clinical documentation for associated physical therapy, rheumatology consultations, or biologic medications billed on the same date.

Common denial triggers for M15.4

• Using the non-billable parent code M15: Automatic technical denial. Always use M15.4 or another specific subcode.
• Missing erosive documentation: If the note describes generalized joint pain without mentioning erosive changes, payers may remap the claim to M15.9 (unspecified) and reimburse at a lower level or request refund.
• Conflicting inflammatory arthritis workup: A positive RF or anti-CCP result in the same encounter without a clear exclusion of RA can prompt a medical necessity review.
• Inconsistent code use across visits: Alternating between M15.4, M15.0, and M19.90 for the same patient without documented clinical rationale signals poor coding hygiene and increases audit risk.

Practices serving patients with musculoskeletal conditions benefit from practice management platforms that track diagnosis code consistency across visits. Reviewing physical therapy clinic requirements by state helps multi-site practices align documentation standards with local payer policies. For larger rheumatology or osteopathy practices, osteopathy practice software with integrated billing checks can flag inconsistent code patterns before claims are submitted.

Conclusion

Accurate use of ICD-10 Code M15.4 comes down to two things: clinical documentation that explicitly supports the erosive osteoarthritis diagnosis, and consistent code selection that reflects the documented presentation at every encounter. The parent code M15 is non-billable, M15.0 is not interchangeable with M15.4, and payers will ask questions when the medical record does not clearly support the erosive pattern.

Pabau helps musculoskeletal and rheumatology practices build documentation templates that capture every required element for M15.4 at the point of care. If your team is spending time responding to ADRs or correcting claim edits for osteoarthritis codes, explore how Pabau’s practice management software keeps clinical records and billing aligned. Book a demo to see the workflow.

Continue your research

Need software designed for musculoskeletal clinics? Physical therapy EMR covers scheduling, documentation, and billing for PT practices managing complex diagnosis codes.

Want to reduce documentation burden at the point of care? Pabau Echo AI generates structured clinical notes automatically from consultations, helping practitioners capture ICD-10-compatible documentation faster.

Managing compliance across a multi-site clinic? Compliance management software from Pabau keeps audit documentation, consent records, and billing trails organized across locations.

Frequently Asked Questions